Intermittent infusions of levosimendan in advanced heart failure: last but not least; a single-centre clinical experience on the efficacy of repeated levosimendan infusions.
Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction in short-term treatment with empagliflozin on top of existing therapy